Displaying 25 - 34 of 34
Immune-Mediated and Cholestatic Diseases
7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View
Liver Tumours
1

Norgine: An Ounce of Prevention is Worth a Pound of Care - ILC 2022

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
Displaying 25 - 34 of 34